According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current Operating Margin is -20.53%. At the end of 2022 the company had an Operating Margin of -20.54%.
Year | Operating Margin | Change |
---|---|---|
2022 | -20.54% | -595.55% |
2021 | 4.14% | -115.67% |
2020 | -26.45% | 253.09% |
2019 | -7.49% | -45.6% |
2018 | -13.77% | -83.23% |
2017 | -82.10% | -2282.43% |
2016 | 3.76% | -68.57% |
2015 | 11.97% | -33.31% |
2014 | 17.95% | 191.64% |
2013 | 6.15% | -31.27% |
2012 | 8.95% | -44.54% |
2011 | 16.14% | -28.63% |
2010 | 22.62% | 42.69% |
2009 | 15.85% | 112.45% |
2008 | 7.46% | -70.17% |
2007 | 25.01% | 197.86% |
2006 | 8.40% | -66.31% |
2005 | 24.92% | 98.12% |
2004 | 12.58% | -52.75% |
2003 | 26.63% | 34.29% |
2002 | 19.83% | 20.49% |
2001 | 16.46% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Novartis NVS | 17.27% | -184.12% | ๐จ๐ญ Switzerland |
Pfizer PFE | 34.61% | -268.58% | ๐บ๐ธ USA |
Sanofi SNY | 18.21% | -188.70% | ๐ซ๐ท France |
Merck MRK | 27.73% | -235.07% | ๐บ๐ธ USA |
AstraZeneca AZN | 5.63% | -127.42% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | 22.54% | -209.79% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | 24.69% | -220.26% | ๐ฎ๐ณ India |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.